CAS Beijing Institute of Genomics and Purple Xin Pharmaceutical Co. will cooperate on 2nd generation DNA sequencer development

Oct 30, 2013

Based on IP of CAS, e. g. on a 2D CCD camera, Purple Xin Pharmaceuticals, a Ginseng-based company, will diversify into sequencer manufacturing through ist Jilin subsidiary Zhongke Zixin.

China Bio news release, October 30, 2013